SPPI Affirms Strong Patent Protection for FUSILEV

  • Uploaded by Karmastock on Dec 11, 2011
  • Views: 231

Spectrum Pharmaceuticals Incorporated - symbol SPPI - reported that the FDA has granted FUSILEV (levoleucovorin) “Orphan Drug” exclusivity for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer

Show Description Hide Description